Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Etazocine is a benzomorphan-type opioid analgesic with mixed agonist-antagonist properties. It primarily acts as an agonist at the kappa-opioid receptor and has antagonistic or partial agonistic activity at the mu-opioid receptor. This pharmacological profile allows it to provide effective analgesia with a lower risk of respiratory depression and physical dependence compared to pure mu-opioid agonists like morphine. In clinical practice, particularly in China and Japan, it is used for the relief of moderate to severe pain, including postoperative pain and as an adjunct to sedative agents like propofol during endoscopic procedures (e.g., enteroscopy) to enhance patient comfort and stability.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on etazocine.